Abstract:
Echinacea purpurea, also known as purple coneflower, has been used extensively in medicinal preparartions for the treatments of colds and an immunostimulant and anti-inflammatory remedy. Compared to abundant pharmacological data and clinical studies, genetic transformation in Echinacea spp. has not been reported yet. The present invention provides a method and medium of producing stable transformation in medicinal plant Echinacea purpurea, by using different tissues of in vitro Echinacea purpurea plantlets and Agrobacterium-mediated method. We have constructed an expression vector pCHS carrying chimeric Petunia chalcone synthase on pBI121-based vector. Chalcone synthase is a key enzyme in synthesizing anthocyanins/flavonoids, a large class of secondary plant metabolites. We have determined the optimal conditions for callus induction, plant regeneration and dosage of antibiotics from different explants of Echinacea purpurea. Several transformants were obtained from antibiotic-containing medium. The presence of the transgenes was demonstrated by PCR and Southern blot analyses, and the T-DNA insertion sites in the transgenic plants were also identified. Transgenic chalcone synthase mRNA expression was detected in transformants but not in wild-type Echinacea plants by Northern blot analysis. As a pioneer, our successful transformation in Echinacea will lead metabolic engineering on this medicinal plant possible, and the relation between the increased levels of flavonols and efficacy in transgenic Echinacea plants can be evaluated.
Fields of Application:
1. In vitro propagation and regeneration of medicinal plant Echinacea purpurea; 2. Genetic transformation in medicinal plant Echinacea purpurea; 3. Pharmaceutical industries which are interested in metabolic engineering to the efficacy in transgenic Echinacea plants; 4. In planta production of secondary metabolites using transgenic Echinacea plants.
Advantages when compared to the existing technologies:
1. This is the first documentation providing an effective method and optimal medium suitable for stable transformation in medicinal plant Echinacea purpurea. 2. Transgenic Echinacea plants which over-expressed Petunia chalcone synthase can be used as a model system for monitoring the relationship between accumulation of plant secondary metabolites (anthocyanins/flavonoids) and the efficacy of this medicinal plant.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you
IP Status:Issued TW I 287576 US pending
